Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

NCT: NCT06041594 · RECRUITING

NCT IDNCT06041594
StatusRECRUITING
Start Date2024-08-19
Completion2026-09
SponsorInnova Vascular, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ System and the Malibu Aspiration Catheter™ System. These devices are manufactured by Innova Vascular, Inc.

Frequently Asked Questions

What is Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)?

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) is a clinical trial registered under NCT06041594. Current status: RECRUITING.

What is the status of NCT06041594?

The current status of NCT06041594 (Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)) is: RECRUITING.

When did Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) start?

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) started on 2024-08-19.

Related Devices

K223929Laguna™ Clot Retriever System and Malibu™ Aspiration Catheter System (Laguna Thrombectomy System)Innova Vascular, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑